|
|
| Line 11: |
Line 11: |
| | MeshID = D008581 | | | MeshID = D008581 |
| }} | | }} |
| {{SI}} | | |
| | {{Meningitis}} |
|
| |
|
| {{CMG}}; '''Associate Editor(s)-In-Chief:''' {{CZ}} | | {{CMG}}; '''Associate Editor(s)-In-Chief:''' {{CZ}} |
|
| |
|
| ==Overview== | | ==[[Meningitis overview|Overview]]== |
| '''Meningitis''' is the [[inflammation]] of the protective membranes covering the [[central nervous system]], known collectively as the [[meninges]] (the leptomeninges and underlying subarachnoid cerebrospinal fluid). Meningitis may develop in response to a number of causes, including infectious agents (bacteria, viruses, fungi, or other organisms), physical injury, [[cancer]], or certain drugs. While some forms of meningitis are mild and resolve on their own, meningitis is a potentially serious condition owing to the proximity of the inflammation to the brain and spinal cord. The potential for serious neurologic damage or even death necessitates prompt medical attention and evaluation. Infectious meningitis, the most common form, is typically treated with [[antibiotic]]s and close observation. <ref>Durand, M.L., et.al., Acute bacterial meningitis: a review of 493 episodes, NEJM 1993; 328: 21-28. PMID 8416268</ref> <ref>Fekete, T., Clinical features of acute bacterial meningitis, in UpToDate, October 5, 1997.</ref> <ref>Quagliarello, V., Scheld, W.M., Bacterial meningitis: pathogenesis, pathophysiology, and progress, NEJM 1992; 327: 864-872. PMID 1508247</ref> <ref>Quagliarello, V., Scheld, W.M., Treatment of bacterial meningitis, NEJM 1997; 336: 708-716. PMID 9041103</ref> <ref>Schuchat, A., et.al., Bacterial meningitis in the United States in 1995, NEJM 1997; 337: 970-976. PMID 9395430</ref> <ref>Townsend, G.C., Scheld, W.M., The use of corticosteroids in the management of bacterial meningitis in adults, J Antimicrobial Chemotherapy 1996; 37: 1061-1061. PMID 8836809 </ref>
| |
|
| |
|
| ==History== | | ==[[Meningitis classification|Classification]]== |
| Meningitis may have been described in the Middle Ages, but it was first accurately identified by the Swiss Vieusseux (a scientific-literary association) during an outbreak in Geneva, Switzerland in 1805.
| |
|
| |
|
| In the 19th century, meningitis was a scourge of the Japanese imperial family, playing the largest role in the horrendous pre-maturity death rate the family endured. In the mid-1800s, only the Emperor Kōmei and two of his siblings reached maturity out of fifteen total children surviving birth. Kōmei's son, the Emperor Meiji, was one of two survivors out of Kōmei's six children, including an elder brother of Meiji who would have taken the throne had he lived to maturity. Five of Meiji's 15 children survived, including only his third son, Emperor Taishō, who was [[feeble-minded]], perhaps as a result of having contracted meningitis himself. By Emperor Hirohito's generation the family was receiving modern medical attention. As the focal point of tradition in Japan, during the Tokugawa Shogunate the family was denied modern "Dutch" medical treatment then in use among the upper caste; despite extensive modernization during the Meiji Restoration the Emperor insisted on traditional medical care for his children.
| | ==[[Meningitis historical perspective|Historical Perspective]]== |
|
| |
|
| ==Epidemiology== | | ==[[Meningitis pathophysiology|Pathophysiology]]== |
| [[Image:Meningite.jpg|thumb|right|350px|Demography of [[meningococcus|meningococcal]] meningitis. Red: meningitis belt, orange: epidemic meningitis, grey: sporadic cases]]
| |
|
| |
|
| Meningitis refers to the inflammation arachnoid matter, the sub-arachnoid space and the cerebrospinal fluid (CSF, including the ventricles). Meningitis can affect anyone in any age group, from the newborn to the elderly. | | ==[[Meningitis epidemiology and demographics|Epidemiology & Demographics]]== |
|
| |
|
| From its recognition in 1805 until the early 20th century, bacterial meningitis was virtually uniformly fatal. Until recent years, up to 50% of patients who survived the acute infection would be left with permanent sequelae such as mental retardation and hearing loss. Over the past several years, there has been a striking shift in the demography of meningitis.
| | ==[[Meningitis epidemiology and demographics|Risk Factors]]== |
| * In 1986, the median age of a patient with meningitis was 15 months, as compared with 25 years in 1995.
| |
| * Before the widespread use of the conjugated Haemophilus influenzae type B (HIB) vaccine in 1990, H. influenzae type b meningitis developed in nearly 1 in 200 children < 5 years old, and almost 70% of the cases of meningitis in children < 5 were due to H influenzae.
| |
| *:* It was necessary to conjugate the H. influenzae type b polysaccharide to a carrier protein in order to make a T-cell dependant antigen that could induce an immune response in infants.
| |
| * In the study by Schuchat et.al. in 1995, H. influenzae only accounted for 7% of cases.
| |
| *:* The case-fatality rate varied significantly amongst the different organisms, and the pathogenic organisms responsible for disease varied greatly with age.
| |
| *:* Group B Streptococcus agalactiae (S. agalactiae) was the main cause of meningitis in infants < 1 month with Listeria accounting for ~ 20% of cases.
| |
| *:*:* In infants 1 month – 23 month of age, Streptococcus pneumoniae (S. pneumoniae) and Neisseria meningitidis (N. meningitidis) caused 45% and 31% of the cases, respectively.
| |
| *:*:* In the 2 – 18 year old age group, N. meningitidis caused 59% of the cases, and in people 19 – 59 years old S. pneumoniae caused 62% of the cases.
| |
| *:* Nosocomial infections with Gram-negative bacilli are becoming increasingly important as well.
| |
|
| |
|
| The "Meningitis Belt" is an area in sub-Saharan Africa which stretches from Senegal in the west to Ethiopia in the east in which large epidemics of meningococcal meningitis occur (this largely coincides with the Sahel region). It contains an estimated total population of 300 million people. The largest epidemic outbreak was in 1996, when over 250,000 cases occurred and 25,000 people died as a consequence of the disease.
| | ==[[Meningitis screening|Screening]]== |
|
| |
|
| == Pathophysiology & Etiology== | | ==[[Meningitis causes|Causes]]== |
|
| |
|
| The clinical picture of meningitis largely arises from the host response to the inciting organism in the CSF.
| | ==[[Meningitis differential diagnosis|Differentiating Meningitis from other Diseases]]== |
| * It seems that the subcapsular components (the cell wall and lipopolysaccharide) of bacteria are more important in determining inflammation than the surface components (pili and polysaccharide capsule).
| |
| * The primary site of breakdown of the blood-brain barrier is the cerebral microvascular endothelium.
| |
| *:* Electron microscope (EM) studies have shown complete separation of the intercellular tight junctions
| |
| * It appears that there is a final common pathway, mediated by TNF-alpha, IL-1 and IL-6, that results in meningeal inflammation and loss of the blood-brain barrier.
| |
| *:* One of the major roles of these cytokines is to facilitate the migration of neutrophils across the vascular endothelium into the CSF.
| |
| *:* A key initial step in this process is obviously adhesion of the PMN to the endothelial surface.
| |
| *:*:* This is mediated by the expression of specific transmembrane glycoproteins expressed on the endothelial surface that interact with specific counterparts on the neutrophils.
| |
| *:*:* These adhesion molecules fall into three large categories: the immunoglobin superfamily (including the antigen-specific T and B cell receptors, ICAM-1 and ICAM-2), the integrin family (beta-1, beta-2, and beta-3) and the selectin family (including ELAM-1).
| |
| *:* The interaction of beta-2 integrin (CD18) and ICAM-1 is largely responsible for PMN diapedesis.
| |
| * Additionally, patients get cerebral edema that is mediated by an increase in capillary permeability, the inflammatory response from the neutrophils, and CSF outflow resistance.
| |
| * The above pathophysiologic processes are not only important in producing the symptoms associated with meningitis, but the understanding of the underlying disease process is necessary to guide therapy (see below).
| |
|
| |
|
| == Mechanism == | | ==[[Meningitis natural history|Natural History, Complications & Prognosis]]== |
| | |
| * In order to gain access to the CNS, the pathogen needs to colonize mucosal epithelium, invade and survive in the intravascular space, cross the blood-brain barrier and survive in the CSF.
| |
| * Colonization of the nasopharynx is usually asymptomatic, and during peak seasons, approximately 20% of the population are colonized with N. meningitidis.
| |
| | |
| ==Causes==
| |
| Most cases of meningitis are caused by [[microorganisms]], such as [[viruses]], [[bacteria]], [[fungi]], or [[parasite]]s, that spread into the blood and into the [[cerebrospinal fluid]] (CSF).<ref name=Sherris>{{cite book | author = Ryan KJ, Ray CG (editors) | title = Sherris Medical Microbiology | pages = 876–9 |edition = 4th ed. | publisher = McGraw Hill | year = 2004 | isbn = 0838585299 }}</ref> Non-infectious causes include [[cancer]]s, [[systemic lupus erythematosus]] and certain [[drugs]]. The most common cause of meningitis is viral, and often runs its course within a few days. Bacterial meningitis is the second most frequent type and can be serious and life-threatening. Numerous microorganisms may cause bacterial meningitis, but ''[[Neisseria meningitidis]]'' ("meningococcus") and ''[[Streptococcus pneumoniae]]'' ("pneumococcus") are the most common pathogens in patients without immune deficiency, with meningococcal disease being more common in children. ''[[Staphylococcus aureus]]'' may complicate neurosurgical operations, and ''[[Listeria monocytogenes]]'' is associated with poor nutritional state and alcoholicism. ''[[Haemophilus influenzae]]'' (type B) incidence has been much reduced by immunization in many countries. ''[[Mycobacterium tuberculosis]]'' (the causative agent of [[tuberculosis]]) rarely causes meningitis in Western countries but is common and feared in countries where tuberculosis is endemic.
| |
|
| |
|
| ==Diagnosis== | | ==Diagnosis== |
| ===History and Symptoms===
| | [[Meningitis history and symptoms|History & Symptoms]] | [[Meningitis physical examination|Physical Examination]] | [[Meningitis staging|Staging]] | [[Meningitis laboratory tests|Lab Tests]] | [[Meningitis electrocardiogram|Electrocardiogram]] | [[Meningitis chest x ray|Chest X Ray]] | [[Meningitis CT|CT]] | [[Meningitis MRI|MRI]] | [[Meningitis echocardiography or ultrasound|Echocardiography or Ultrasound]] | [[Meningitis other imaging findings|Other Imaging Findings]] | [[Meningitis other diagnostic studies|Other Diagnostic Studies]] |
| | |
| In the study by Durand et.al., only 2/3 of patients had the classic triad of [[fever]], [[nuchal rigidity]] and [[mental status|change in mental status]].
| |
| * All patients, however, had at least one of these findings.
| |
| * 95% had fever >100 degrees Fahrenheit, with a mean duration of 4 days.
| |
| * [[Neck stiffness]] was present in 88%, and contrary to other reports, was not significantly lower amongst the elderly.
| |
| *:* [[Kernig's sign]]: inability to allow full extension of the knee when the hip is flexed 90 degrees.
| |
| *:* [[Brudzinski’s sign]]: spontaneous flexion of the hips during attempted passive neck flexion.
| |
| * 11% of patients had a rash, and of these cases 73% of them were due to [[Neisseria meningitidis]] (most commonly [[petechiae]] and [[purpura]])
| |
| * 78% of patients had an abnormal mental status, primarily [[lethargy]] and [[confusion]].
| |
| *:* 23% of the patients had focal [[seizure]]s.
| |
| | |
| In general:
| |
| | |
| [[Headache]] is the most common symptom of meningitis (87%) followed by [[nuchal rigidity]] ("neck stiffness", 83%). The classic triad of diagnostic signs consists of nuchal rigidity (being unable to flex the neck forward), [[fever]] and altered mental status. All three features are present in only 44% of all cases of infectious meningitis.<ref>{{cite journal |author=van de Beek D, de Gans J, Spanjaard L, Weisfelt M, Reitsma JB, Vermeulen M |title=Clinical features and prognostic factors in adults with bacterial meningitis |journal=N. Engl. J. Med. |volume=351 |issue=18 |pages=1849-59 |year=2004 |pmid=15509818 |doi=10.1056/NEJMoa040845}}</ref> Other symptoms commonly associated with meningitis are [[photophobia]] (inability to tolerate bright light), [[phonophobia]] (inability to tolerate loud noises), [[irritability]] and [[delirium]] (in small children) and [[seizure]]s (in 20-40% of cases). In infants (0-6 months), swelling of the [[fontanelle]] (soft spot) may be present. [[Vomiting]] may be present.
| |
| | |
| ===Physical Examination===
| |
| The suspicion of meningitis is generally based on the nature of the symptoms and findings on [[physical examination]]. Meningitis is a [[medical emergency]], and referral to hospital is indicated. If meningitis is suspected based on clinical examination, early administration of [[antibiotic]]s is recommended, as the condition may deteriorate rapidly. In the hospital setting, initial management consists of stabilization (e.g. securing the [[airway]] in a depressed level of consciousness, administration of [[intravenous fluid]]s in [[hypotension]] or [[Shock (medical)|shock]]), followed by antibiotics if not already administered.
| |
| | |
| Nuchal rigidity is typically assessed with the patient lying [[Supine position|supine]], and both hips and knees flexed. If pain is elicited when the knees are passively extended ([[Kernig's sign]]), this indicates nuchal rigidity and meningitis. In infants, forward flexion of the neck may cause involuntary knee and hip flexion ([[Brudzinski's sign]]). Although commonly tested, the sensitivity and specificity of Kernig's and Brudzinski's tests are uncertain.<ref name=Thomas_2002>{{cite journal |author=Thomas KE, Hasbun R, Jekel J, Quagliarello VJ |title=The diagnostic accuracy of Kernig's sign, Brudzinski's sign, and nuchal rigidity in adults with suspected meningitis |journal=Clin. Infect. Dis. |volume=35 |issue=1 |pages=46-52 |year=2002 |pmid=12060874 |doi=}}</ref>
| |
| | |
| In "meningococcal" meningitis (i.e. meningitis caused by the bacteria [[Neisseria meningitidis]]), a rapidly-spreading [[petechial rash]] is typical, and may precede other symptoms. The rash consists of numerous small, irregular purple or red spots on the trunk, lower extremities, mucous membranes, conjunctiva, and occasionally on the palms of hands and soles of feet.
| |
| | |
| ===Laboratory Evaluations===
| |
| | |
| Investigations include [[blood test]]s (electrolytes, liver and kidney function, inflammatory markers and a [[complete blood count]]) and usually [[X-ray]] examination of the chest. The most important test in identifying or ruling out meningitis is analysis of the [[cerebrospinal fluid]] (fluid that envelops the brain and the spinal cord) through [[lumbar puncture]] (LP). However, if the patient is at risk for a cerebral mass lesion or elevated [[intracranial pressure]] (recent head injury, a known immune system problem, localizing neurological signs, or evidence on examination of a raised ICP), a lumbar puncture may be contraindicated because of the possibility of fatal [[brain herniation]]. In such cases a [[Computed tomography|CT]] or [[Magnetic resonance imaging|MRI]] scan is generally performed prior to the lumbar puncture to exclude this possibility. Otherwise, the CT or MRI should be performed after the LP, with MRI preferred over CT due to its superiority in demonstrating areas of cerebral edema, ischemia, and meningeal inflammation.
| |
| | |
| During the lumbar puncture procedure, the opening pressure is measured. A pressure of over 180 mmH<sub>2</sub>O is indicative of bacterial meningitis.
| |
| | |
| The CSF sample is examined for [[white blood cell]]s (and which subtypes), [[red blood cell]]s, [[protein]] content and [[glucose]] level. [[Gram staining]] of the sample may demonstrate bacteria in bacterial meningitis, but absence of bacteria does not exclude bacterial meningitis; [[microbiological culture]] of the sample may still yield a causative organism. The type of white blood cell predominantly present predicts whether meningitis is due to bacterial or [[virus|viral]] infection. Other tests performed on the CSF sample include [[latex agglutination test]], limulus lysates, or [[polymerase chain reaction]] (PCR) for bacterial or viral DNA. If the patient is [[immunodeficiency|immunocompromised]], testing the CSF for [[toxoplasmosis]], [[Epstein-Barr virus]], [[cytomegalovirus]], [[JC virus]] and [[fungi|fungal infection]] may be performed.
| |
| [[Image:Streptococcus pneumoniae meningitis, gross pathology 33 lores.jpg|thumb|200px|right|An [[autopsy]] demonstrating signs of [[pneumococcus|pneumococcal]] '''meningitis'''. The [[forceps]] (center) are retracting the [[dura mater]] (white). Underneath the dura mater are the [[leptomeninges]], which are [[edema]]tous and have multiple small [[hemorrhage|hemorrhagic]] foci (red).]] | |
| | |
| {| style="background:#FDF5E6;padding:0.3em; margin-left:5px; border:1px solid #996666"
| |
| |+ style="color:#996666"|'''CSF finding in different conditions'''<ref>{{cite book |last=Provan |first= Drew|authorlink= |coauthors=Andrew Krentz |title= Oxford Handbook of clinical and laboratory investigation|year=2005 |publisher=Oxford university press |location=Oxford |isbn=0198566638 }}</ref>
| |
| !bgcolor="#FFEFD5"|Condition !! bgcolor="#FFEFD5"|Glucose !! bgcolor="#FFEFD5"|Protein!!bgcolor="#FFEFD5"|Cells
| |
| |-
| |
| ! bgcolor="#FFEFD5"|Acute bacterial meningitis
| |
| | Low|| high||high, often > 300/mm³
| |
| |-
| |
| ! bgcolor="#FFEFD5"|Acute viral meningitis
| |
| |Normal ||normal or high|| [[Lymphocyte|mononuclear]], < 300/mm³
| |
| |-
| |
| ! bgcolor="#FFEFD5"|Tuberculous meningitis
| |
| |Low ||high||[[pleocytosis]], mixed < 300/mm³
| |
| |- | |
| ! bgcolor="#FFEFD5"|Fungal meningitis
| |
| |Low||high||< 300/mm³
| |
| |-
| |
| ! bgcolor="#FFEFD5"|Malignant meningitis
| |
| |Low ||high||usually mononuclear
| |
| |-
| |
| ! bgcolor="#FFEFD5"|Subarachnoid haemorrhage
| |
| |Normal ||normal, or high ||[[Erythrocytes]]
| |
| |}
| |
| | |
| | |
| {|
| |
| |-style="background:silver; color:black"
| |
| | '''Cerebrospinal Fluid''' || || || || || | |
| |-style="background:silver; color:black"
| |
| | || '''Normal Levels''' || '''Acute Bacterial M.''' || '''Acute Viral M.''' || '''TB M.''' || '''Neuroborreliosis'''
| |
| |- style="background:silver; color:black"
| |
| | '''Cells/ul''' || '''< 5''' || '''In the 1000s''' || '''In the 100s''' || '''In the 100s''' || '''Some 100'''
| |
| |-style="background:silver; color:black"
| |
| | '''Cells''' || '''Lymph:Monos 7:3''' || '''Gran. > Lymph.''' || '''Lymph. > Gran.''' || '''Various leukos''' || '''Lymph. monocytic'''
| |
| |-style="background:silver; color:black"
| |
| | '''Total Protein (mg/dl)''' || '''45-60''' || '''Typically 100-500''' || '''Typically normal''' || '''Typically 100-200''' || '''Typically up to 350'''
| |
| |-style="background:silver; color:black"
| |
| | '''Glucose Ratio (CSF/plasma)''' || '''Typically > 0.5''' || '''< 0.3''' || '''> 0.6''' || '''< 0.5''' || '''Normal'''
| |
| |-style="background:silver; color:black"
| |
| | '''Lactate (mmol/l)''' || '''< 2.1''' || '''> 2.1''' || '''< 2.1''' || '''> 2.1''' || '''-'''
| |
| |-style="background:silver; color:black"
| |
| | '''Others''' || '''ICP: 6-22 (cm H2O)''' || || '''PCR of HSV-DNA''' || '''PCR of TBC-DNA''' || '''IgG/IgM <br> CSF/Serum Ratio'''
| |
| |}
| |
| {{clr}}
| |
| | |
| In bacterial meningitis, the CSF glucose to serum glucose ratio is < 0.4. The Gram stain is positive in >60% of cases, and culture in >80%. Latex agglutination may be positive in meningitis due to ''[[Streptococcus pneumoniae]]'', ''[[Neisseria meningitidis]]'', ''[[Haemophilus influenzae]]'', ''[[Escherichia coli]]'', Group B Streptococci. Limulus lysates may be positive in Gram-negative meningitis.
| |
| | |
| ====CSF Cultures====
| |
| Cultures are often negative if CSF is taken after the administration of antibiotics. In these patients, [[polymerase chain reaction|PCR]] can be helpful in arriving at a diagnosis. It has been suggested that CSF [[cortisol]] measurement may be helpful.<ref>{{cite journal | title=Cortisol levels in cerebrospinal fluid correlate with severity and bacterial origin of meningitis | author=Holub M, Beran O, Dzupova O, ''et al.'' | journal=Critical Care | year=2007 | volume=11 | pages=R41 | doi=10.1186/cc5729 }}</ref>
| |
| | |
| ===Prediction rules===
| |
| The Bacterial Meningitis Score predicts reliably whether a child (older than two months) may have infectious meningitis. In children with at least 1 risk factor (positive CSF Gram stain, CSF absolute neutrophil count ≥ 1000 cell/µL, CSF protein ≥ 80 mg/dL, peripheral blood absolute neutrophil count ≥ 10,000 cell/µL, history of seizure before or at presentation time) it had a [[sensitivity (tests)|sensitivity]] of 100%, [[specificity (tests)|specificity]] of 63.5%, and negative predictive value of 100%.<ref>{{cite journal |author=Nigrovic LE, Kuppermann N, Macias CG, ''et al'' |title=Clinical prediction rule for identifying children with cerebrospinal fluid pleocytosis at very low risk of bacterial meningitis |journal=JAMA |volume=297 |issue=1 |pages=52-60 |year=2007 |pmid=17200475 |doi=10.1001/jama.297.1.52}}</ref>
| |
| | |
| ===Computed Tomography===
| |
| * The role of the head CT is controversial. It should obviously be preformed in all patients with suspected elevations in intracranial pressure (ICP), however this is often a difficult clinical diagnosis.
| |
| *:* Approximately 50% of the patients in Durand’s study with focal neuro findings had CT abnormalities, whereas CT findings were seen in only 17% of patients without focal findings on exam (p < 0.01).
| |
| *:* Quagliarello and Scheld recommend getting CTs only in patients who are comatose, have papilledema or who have focal neuro deficits.
| |
| | |
| === Histopathology: Acute Bacterial Meningitis ===
| |
| | |
| <youtube v=L9jpjxTSLws/>
| |
| | |
| ==Complete Differential Diagnosis of Underlying Causes of Meningitis==
| |
| | |
| In alphabetical order. <ref>Sailer, Christian, Wasner, Susanne. Differential Diagnosis Pocket. Hermosa Beach, CA: Borm Bruckmeir Publishing LLC, 2002:77 ISBN 1591032016</ref> <ref>Kahan, Scott, Smith, Ellen G. In A Page: Signs and Symptoms. Malden, Massachusetts: Blackwell Publishing, 2004:68 ISBN 140510368X</ref>
| |
| | |
| === Common Causes ===
| |
| * [[Escherichia coli]]
| |
| * [[Gram-negative bacilli]]
| |
| * [[Group B streptococci]]
| |
| * [[Haemophilus influenzae]]
| |
| * [[Klebsiella pneumoniae]]
| |
| * [[Listeria monocytogenes]]
| |
| * [[Neisseria Meningitis]]
| |
| * [[Non-Group B streptococci]]
| |
| * [[Staphylococci]]
| |
| * [[Streptococcus agalactiae]]
| |
| * [[Streptococcus pneumoniae]]
| |
| | |
| === Infectious Causes ===
| |
| * [[Abscess]]
| |
| * [[Adenovirus]]
| |
| * [[Arboviruses]]
| |
| * [[Aspergillosis]]
| |
| * [[Borrelia]]
| |
| * [[Candidiasis]]
| |
| * [[Chlamydia psittaci]]
| |
| * [[Coccidioidomycosis]]
| |
| * [[Coxsackie viruses]]
| |
| * [[Cryptococcosis]]
| |
| * [[Cysticercosis]]
| |
| * [[Cytomegalovirus]]
| |
| * [[ECHO viruses]] ('''E'''ntero '''C'''ytopathogenic '''H'''uman '''O'''rphan)
| |
| * [[Epstein-Barr Virus]]
| |
| * [[Escherichia coli]]
| |
| * [[Haemophilus influenzae]]
| |
| * [[Herpes Simplex Virus]]
| |
| * [[Histoplasmosis]]
| |
| * [[HIV]]
| |
| * [[Influenza]]
| |
| * [[Klebsiella pneumoniae]]
| |
| * [[Leptospira]]
| |
| * [[Listeria monocytogenes]]
| |
| * [[Malaria]]
| |
| * [[Measles]]
| |
| * [[Mumps]]
| |
| * [[Mycobacteria]]
| |
| * [[Mycoplasma pneumoniae]]
| |
| * [[Neisseria Meningitidis]]
| |
| * [[Otitis]]
| |
| * [[Pertussis]]
| |
| * [[Polio]]
| |
| * [[Proteus]]
| |
| * [[Pseudomonas]]
| |
| * [[Rabies]]
| |
| * [[Rickettsia]]
| |
| * [[Rubella]]
| |
| * [[Sarcoidosis]]
| |
| * [[Schistosomiasis]]
| |
| * [[Sinusitis]]
| |
| * [[Smallpox]]
| |
| * [[Staphylococcus aureus]]
| |
| * [[Staphylococcus epidermidis]]
| |
| * [[Streptococci]]
| |
| * [[Streptococcus agalactiae]]
| |
| * [[Streptococcus pneumoniae]]
| |
| * [[Syphilis]]
| |
| * [[Toxoplasmosis]]
| |
| * [[Tuberculosis]]
| |
| * [[Varicella-Zoster Virus]]
| |
| * [[Whipple's Disease]]
| |
| | |
| === Noninfectious Causes ===
| |
| * [[Behcet's Syndrome]]
| |
| * [[Brain tumor]]
| |
| * [[Cerebrovascular accident]]
| |
| * [[Drugs]]
| |
| * Meningeal carcinomatosis
| |
| * Meningeal [[leukemia]]
| |
| * [[Multiple Sclerosis]]
| |
| * Vaccine reaction
| |
| * Triquinine
| |
|
| |
|
| ==Treatment== | | ==Treatment== |
| | '''Medical therapy:''' [[Meningitis medical therapy#Bacterial meningitis|Bacterial meningitis]] | [[Meningitis medical therapy#Viral meningitis|Viral meningitis]] | [[Meningitis medical therapy#Fungal meningitis|Fungal meningitis]] |
|
| |
|
| ===Bacterial meningitis===
| | [[Meningitis surgery|Surgery]] | [[Meningitis primary prevention|Primary Prevention]] | [[Meningitis secondary prevention|Secondary Prevention]] |
| Bacterial meningitis is a [[medical emergency]] and has a high mortality rate if untreated.<ref name=Beckham_2006>{{cite journal |author=Beckham J, Tyler K |title=Initial Management of Acute Bacterial Meningitis in Adults: Summary of IDSA Guidelines |journal=Rev Neurol Dis |volume=3 |issue=2 |pages=57-60 |year=2006 |pmid=16819421}}</ref> All suspected cases, however mild, need emergency medical attention. Empiric antibiotics must be started immediately, even before the results of the [[lumbar puncture]] and [[Cerebrospinal fluid|CSF]] analysis are known. Antibiotics started within 4 hours of lumbar puncture will not significantly affect lab results. Adjuvant treatment with [[corticosteroids]] reduces rates of mortality, severe hearing loss and neurological sequelae.<ref>{{cite journal |author=van de Beek D, de Gans J, McIntyre P, Prasad K |title=Corticosteroids for acute bacterial meningitis |journal=Cochrane database of systematic reviews (Online) |volume= |issue=1 |pages=CD004405 |year=2007 |pmid=17253505 |doi=10.1002/14651858.CD004405.pub2}}</ref>
| |
|
| |
|
| {| class = "prettytable" style = "float:right; font-size:85%; margin-left:15px"
| | ==Related chapters== |
| |-
| |
| ! Age group
| |
| ! Causes
| |
| |-
| |
| | [[Neonate]]s
| |
| | Group B Streptococci, ''[[Escherichia coli]]'', ''[[Listeria monocytogenes]]''
| |
| |-
| |
| | Infants
| |
| | ''[[Neisseria meningitidis]]'', ''[[Haemophilus influenzae]]'', ''[[Streptococcus pneumoniae]]''
| |
| |-
| |
| | Children
| |
| |''N. meningitidis'', ''S. pneumoniae''
| |
| |-
| |
| | Adults
| |
| | ''S. pneumoniae'', ''N. meningitidis'', Mycobacteria, Cryptococci
| |
| |}
| |
| The choice of antibiotic depends on local advice. In most of the developed world, the most common organisms involved are ''[[Streptococcus pneumoniae]]'' and ''[[Neisseria meningitidis]]'': first line treatment in the UK is a third-generation [[cephalosporin]] (such as [[ceftriaxone]] or [[cefotaxime]]). In those under 3 years of age, over 50 years of age, or immunocompromised, [[ampicillin]] should be added to cover ''[[Listeria monocytogenes]]''. In the U.S. and other countries with high levels of penicillin resistance, the first line choice of antibiotics is [[vancomycin]] and a [[carbapenem]] (such as [[meropenem]]). In sub-Saharan Africa, oily [[chloramphenicol]] or [[ceftriaxone]] are often used because only a single dose is needed in most cases.
| |
| | |
| Staphylococci and gram-negative bacilli are common infective agents in patients who have just had a neurosurgical procedure. Again, the choice of antibiotic depends on local patterns of infection: [[cefotaxime]] and [[ceftriaxone]] remain good choices in many situations, but [[ceftazidime]] is used when ''[[Pseudomonas aeruginosa]]'' is a problem, and intraventricular [[vancomycin]] is used for those patients with intraventricular shunts because of high rates of [[Staphylococcus|staphylococcal]] infection. In patients with intracerebral prosthetic material (metal plates, electrodes or implants, etc.) then sometimes [[chloramphenicol]] is the only antibiotic that will adequately cover infection by ''[[Staphylococcus aureus]]'' (cephalosporins and carbapenems are inadequate under these circumstances).
| |
| | |
| Once the results of the CSF analysis are known along with the Gram-stain and culture, empiric therapy may be switched to therapy targeted to the specific causative organism and its sensitivities.
| |
| *''[[Neisseria meningitidis]]'' (Meningococcus) can usually be treated with a 7-day course of IV antibiotics:
| |
| **Penicillin-sensitive -- [[penicillin]] G or [[ampicillin]]
| |
| **Penicillin-resistant -- [[ceftriaxone]] or [[cefotaxime]]
| |
| **Prophylaxis for close contacts (contact with oral secretions) -- [[rifampin]] 600 mg bid for 2 days ''(adults)'' or 10 mg/kg bid ''(children)''. Rifampin is not recommended in pregnancy and as such, these patients should be treated with single doses of [[ciprofloxacin]], [[azithromycin]], or [[ceftriaxone]]
| |
| *''[[Streptococcus pneumoniae]]'' (Pneumococcus) can usually be treated with a 2-week course of IV antibiotics:
| |
| **Penicillin-sensitive -- [[penicillin]] G
| |
| **Penicillin-intermediate -- [[ceftriaxone]] or [[cefotaxime]]
| |
| **Penicillin-resistant -- [[ceftriaxone]] or [[cefotaxime]] + [[vancomycin]]
| |
| *''[[Listeria monocytogenes]]'' is treated with a 3-week course of IV [[ampicillin]] + [[gentamicin]].
| |
| *Gram negative bacilli -- [[ceftriaxone]] or [[cefotaxime]]
| |
| *''[[Pseudomonas aeruginosa]]'' -- [[ceftazidime]]''
| |
| *''[[Staphylococcus aureus]]''
| |
| **Methicillin-sensitive -- [[nafcillin]]
| |
| **Methicillin-resistant -- [[vancomycin]]
| |
| *''[[Streptococcus agalactiae]]'' -- [[penicillin]] G or [[ampicillin]]
| |
| *''[[Haemophilus influenzae]]'' -- [[ceftriaxone]] or [[cefotaxime]]
| |
| | |
| ===Viral meningitis===
| |
| Unlike bacteria, viruses cannot be killed by antibiotics. Patients with very mild viral meningitis may only have to spend a few hours in a hospital, while those who have a more serious infection may be hospitalised for many more days for supportive care. Patients with mild cases, which often cause only flu-like symptoms, may be treated with fluids, bed rest (preferably in a quiet, dark room), and analgesics for pain and fever. Serious cases, especially in the case of young children or neonates, may require the use of antiviral drugs, such as [[acyclovir]]. The physician may also prescribe [[anticonvulsant]]s such as [[phenytoin]] to prevent [[seizure]]s and [[corticosteroid]]s to reduce brain inflammation. If inflammation is severe, pain medicine and sedatives may be prescribed to make the patient more comfortable.
| |
| | |
| ===Fungal meningitis===
| |
| This form of meningitis is rare in otherwise healthy people, but is a higher risk in those who have [[AIDS]], other forms of [[immunodeficiency]] (an immune system that does not respond adequately to infections) and [[immunosuppression]] (immune system malfunction as a result of medical treatment). In AIDS, ''[[Cryptococcus neoformans]]'' is the most common cause of fungal meningitis; it requires Indian ink staining of the CSF sample for identification of this capsulated yeast. Fungal meningitis is treated with long courses of highly dosed [[Antifungal drug|antifungals]].<ref>{{cite journal |author=Gottfredsson M, Perfect JR |title=Fungal meningitis |journal=Seminars in neurology |volume=20 |issue=3 |pages=307-22 |year=2000 |pmid=11051295 |doi=}}</ref>
| |
| | |
| ==Complications==
| |
| In children there are several potential disabilities which result from damage to the nervous system. These include [[sensorineural]] hearing loss, [[epilepsy]], [[cerebral oedema|diffuse brain swelling]], [[hydrocephalus]], cerebral vein thrombosis, [[Intracranial hemorrhage|intra cerebral bleeding]] and [[cerebral palsy]].<ref> {{cite journal|title=Neurological complications of pneumococcal meningitis|journal=Developmental Medicine and Child Neurology|date=Jan 2004|first=G|last=Vasallo|coauthors=T R Martland|volume=Vol. 46|issue=|pages= pg. 11|id= |url=|format=|accessdate=2007-09-03 }}</ref> Acute neurological complications may lead to adverse consequences. In childhood acute bacterial meningitis deafness is the most common serious complication. [[Sensorineural hearing loss]] often develops during first few days of the illness as a result of [[inner ear]] dysfunction, but permanent deafness is rare and can be prevented by prompt treatment of meningitis.<ref name="pmid9068303">{{cite journal |author=Richardson MP, Reid A, Tarlow MJ, Rudd PT |title=Hearing loss during bacterial meningitis |journal=Arch. Dis. Child. |volume=76 |issue=2 |pages=134-8 |year=1997 |pmid=9068303 |doi=}}</ref>
| |
| | |
| Those contract the disease during [[neonatal]] period and those infected by S pneumoniae and gram negative [[bacilli]] are in greater risk of developing neurological, auditory, or intellectual impairments or functionally important behaviour or learning disorders which can manifest as poor school performance.<ref name="pmid11546680">{{cite journal |author=Grimwood K |title=Legacy of bacterial meningitis in infancy. Many children continue to suffer functionally important deficits |journal=BMJ |volume=323 |issue=7312 |pages=523-4 |year=2001 |pmid=11546680 |doi=}}</ref>
| |
| | |
| In adults [[central nervous system]] complications include [[cerebrovascular disease]], brain swelling, [[hydrocephalus]], intrcerebral bleeding; systemic complications are dominated by septic [[shock]], [[adult respiratory distress syndrome]] and [[disseminated intravascular coagulation]].<ref name="pmid8503793">{{cite journal |author=Pfister HW, Feiden W, Einhäupl KM |title=Spectrum of complications during bacterial meningitis in adults. Results of a prospective clinical study |journal=Arch. Neurol. |volume=50 |issue=6 |pages=575-81 |year=1993 |pmid=8503793 |doi=}}</ref> Those who have underlying predisposing conditions e.g. head injury may develop recurrent meningitis.<ref name="pmid17682979">{{cite journal |author=Adriani KS, van de Beek D, Brouwer MC, Spanjaard L, de Gans J |title=Community-acquired recurrent bacterial meningitis in adults |journal=Clin. Infect. Dis. |volume=45 |issue=5 |pages=e46-51 |year=2007 |pmid=17682979 |doi=10.1086/520682}}</ref> The case-fatality ratio is highest for [[gram-negative]] [[etiology]] and lowest for meningitis caused by [[Haemophilus influenzae|''H influenzae'']] (also a gram negative bacili). Fatal outcome in patients over 60 years of age are more likely to be from systemic complications e.g. [[pneumonia]], [[sepsis]], cardio-respiratory failure; however in younger individuals it is usually associated with neurological complications.<ref name="pmid17682979">{{cite journal |author=Adriani KS, van de Beek D, Brouwer MC, Spanjaard L, de Gans J |title=Community-acquired recurrent bacterial meningitis in adults |journal=Clin. Infect. Dis. |volume=45 |issue=5 |pages=e46-51 |year=2007 |pmid=17682979 |doi=10.1086/520682}}</ref> Age more than 60, low [[glasgow coma scale]] at presentation and [[seizure]] within 24 hours increase the risk of death among community acquired meningitis.<ref name="pmid8416268">{{cite journal |author=Durand ML, Calderwood SB, Weber DJ, ''et al'' |title=Acute bacterial meningitis in adults. A review of 493 episodes |journal=N. Engl. J. Med. |volume=328 |issue=1 |pages=21-8 |year=1993 |pmid=8416268 |doi=}}</ref>
| |
| | |
| == Risk Stratification and Prognosis==
| |
| | |
| The overall mortality rate in Durand’s study was 25%
| |
| * Three factors were associated with a significantly higher mortality:
| |
| *:* Age > 60 (37% vs. 17%, p < 0.001, RR 2.1).
| |
| *:* Obtunded mental status on admission (49% vs. 16%, p < 0.001, RR 3.0).
| |
| *:* Onset of seizures within 48 hours of admission (72% vs. 18%, p < 0.001, RR 4.0).
| |
| *:* 98% of the patients in this study who died had at least one of these three risk factors.
| |
| | |
| ==Prevention==
| |
| ===Immunization===
| |
| All current vaccines target only bacterial meningitis.
| |
| | |
| Vaccinations against ''[[Haemophilus influenzae]]'' ([[Hib vaccine|Hib]]) have decreased early childhood meningitis significantly.<ref name="pmid10756001">{{cite journal |author=Peltola H |title=Worldwide Haemophilus influenzae type b disease at the beginning of the 21st century: global analysis of the disease burden 25 years after the use of the polysaccharide vaccine and a decade after the advent of conjugates |journal=Clin. Microbiol. Rev. |volume=13 |issue=2 |pages=302-17 |year=2000 | url=http://cmr.asm.org/cgi/content/full/13/2/302 |pmid=10756001 |accessdate=2007-09-03}}</ref>
| |
| | |
| Vaccines against type A and C ''[[Neisseria meningitidis]]'', the kind that causes most disease in preschool children and teenagers in the United States, have also been around for a while. Type A is also prevalent in sub-Sahara Africa and W135 outbreaks have affected those on the Hajj pilgrimage to Mecca.
| |
| | |
| A vaccine called ''[[MeNZB]]'' for a specific strain of type B Neisseria meningitidis prevalent in New Zealand has completed trials and is being given to many people in the country under the age of 20. There is also a vaccine, MenBVac, for the specific strain of type B meningoccocal disease prevalent in Norway, and another specific vaccine for the strain prevalent in Cuba.
| |
| | |
| [[Pneumococcal polysaccharide vaccine]] against ''[[Streptococcus pneumoniae]]'' is recommended for all people 65 years of age or older. [[Pneumococcal conjugate vaccine]] is recommended for all newborns starting at 6 weeks - 2 months, according to American Association of Pediatrics (AAP) recommendations.
| |
| | |
| ===Prophylaxis===
| |
| In cases of meningococcal meningitis, prophylactic treatment of close relatives with antibiotics (e.g. [[rifampicin]], [[ciprofloxacin]] or [[ceftriaxone]]) may reduce the risk of further cases.<ref>{{cite journal |author=Fraser A, Gafter-Gvili A, Paul M, Leibovici L |title=Antibiotics for preventing meningococcal infections |journal=Cochrane database of systematic reviews (Online) |volume= |issue=4 |pages=CD004785 |year=2006 |pmid=17054214 |doi=10.1002/14651858.CD004785.pub3}}</ref>
| |
| | |
| ===Pathological Findings===
| |
| | |
| Images shown below are courtesy of Professor Peter Anderson DVM PhD and published with permission. [http://www.peir.net © PEIR, University of Alabama at Birmingham, Department of Pathology]
| |
| | |
| <div align="left">
| |
| <gallery heights="175" widths="175">
| |
| Image:Meningitis 1.jpg|Meningitis: Gross, purulent leptomeningitis due to pneumococcus infection, an excellent example.
| |
| Image:Meningitis 2.jpg|Bacterial Meningitis: Gross, basilar view
| |
| </gallery>
| |
| </div>
| |
| | |
| | |
| <div align="left">
| |
| <gallery heights="175" widths="175">
| |
| Image:Meningitis 3.jpg|Bacterial Meningitis: Gross close-up
| |
| Image:Meningitis 4.jpg|Meningitis: Gross base of frontal lobes well shown meningitis burn case with Pseudomonas sepsis
| |
| </gallery>
| |
| </div>
| |
| | |
| | |
| <div align="left">
| |
| <gallery heights="175" widths="175">
| |
| Image:Meningitis 5.jpg|Meningitis: Gross natural color excellent demonstration of greenish pus in subarachnoid space
| |
| Image:Meningitis 6.jpg|Tuberculous Meningitis: Gross fixed tissue close-up of large areas of necrosis in frontal parasagittal cortex secondary to tuberculous vasculitis. An excellent example
| |
| </gallery>
| |
| </div>
| |
| | |
| | |
| <div align="left">
| |
| <gallery heights="175" widths="175">
| |
| Image:Meningitis 7.jpg|Tuberculous Meningitis: Micro low mag H&E. An excellent example with giant cells.
| |
| Image:Meningitis 8.jpg|Purulent Meningitis: Gross natural color excellent photo lateral aspect of brain with easily seen purulent exudate due to Pneumococcus infection.
| |
| </gallery>
| |
| </div>
| |
| | |
| | |
| <div align="left">
| |
| <gallery heights="175" widths="175">
| |
| Image:Meningitis 9.jpg|Purulent Meningitis: Gross natural color close-up view outstanding example of purulent exudate adjacent to blood vessels
| |
| Image:Meningitis 10.jpg|Purulent Meningitis: Gross natural color Staphylococcal meningitis.
| |
| </gallery>
| |
| </div>
| |
| | |
| | |
| <div align="left">
| |
| <gallery heights="175" widths="175">
| |
| Image:Meningitis 11.jpg|Ependymitis Granular Neoplastic: Gross fixed tissue close-up view and a spectacular one of this lesion case also has carcinomatous meningitis primary is lung oat cell.
| |
| Image:Meningitis 12.jpg|Purulent Meningitis: Gross natural color brain in situ with removed calvarium very good illustration of exudate in meninges over convexities pneumococcus.
| |
| </gallery>
| |
| </div>
| |
| | |
| == Acute pyogenic (bacterial) meningitis ==
| |
| | |
| <youtube v=L9jpjxTSLws/>
| |
| | |
| ==See also==
| |
| * [[Aseptic meningitis]] | | * [[Aseptic meningitis]] |
| * [[Encephalitis]] | | * [[Encephalitis]] |
|
| |
| ==References==
| |
| {{Reflist|2}}
| |
|
| |
|
| {{Diseases of the nervous system}} | | {{Diseases of the nervous system}} |
| {{SIB}}
| |
|
| |
|
| [[af:Meningitis]] | | [[af:Meningitis]] |
| Line 424: |
Line 89: |
| {{WikiDoc Help Menu}} | | {{WikiDoc Help Menu}} |
| {{WikiDoc Sources}} | | {{WikiDoc Sources}} |
| | |
| | [[Category:Disease]] |
| | [[Category:Infectious disease]] |
| | [[Category:Neurology]] |
| | [[Category:Emergency medicine]] |
|
| |
|
| [[Category:Diseases involving the fasciae]] | | [[Category:Diseases involving the fasciae]] |
| Line 429: |
Line 99: |
| [[Category:Medical emergencies]] | | [[Category:Medical emergencies]] |
| [[Category:Neurological disorders]] | | [[Category:Neurological disorders]] |
| [[Category:Infectious disease]]
| | |
| [[Category:Neurology]]
| |
| [[Category:Emergency medicine]]
| |
| [[Category:Overview complete]] | | [[Category:Overview complete]] |
| [[Category:Disease]]
| |